HomeAI · summaries
Storia in 2 fonti
Attovia adds to biotech IPO momentum with $289M offering
The startup is the 12th drug company to bank at least $250 million in an IPO this year, nearly matching totals last seen during the sector’s pandemic peak, according to BioPharma Dive data.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
biopharmadive.com
Attovia adds to biotech IPO momentum with $289M offering
The startup is the 12th drug company to bank at least $250 million in an IPO this year, nearly matching totals last seen during the sector’s pandemic peak, according to BioPharma…
- ·
endpoints.news
Attovia extends biotech IPO streak with $289M listing for three I&I drugs
Attovia Therapeutics (ATTO) raises upsized IPO on Nasdaq, extending biotech's 3-week streak. CEO Tao Fu's firm targets I&I with drugs ATTO-1310, ATTO-2306, ATTO-1091.